Hydrogen Research Study
← Back to Research Library
Preclinical animal evidenceAnimal studyOther or not reported

[Effects of hydrogen gas on NOD-like receptor protein 3 inflammasomes in the cerebral cortex of rats with traumatic brain injury].

Lingling Liu, Hongtao Zhang, Jiwei Wang, Yonghao Yu, Jun Chen · Zhonghua wei zhong bing ji jiu yi xue · 2023

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Inflammation and Immune Regulation
Evidence type Preclinical animal evidence
Publication type Animal study
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

In an animal model, the mechanism by which hydrogen gas alleviates TBI may be related to inhibiting NLRP3 inflammasomes in the cerebral cortex of rats. These preclinical findings add evidence about the molecular-hydrogen effects, outcomes, and biological pathways measured in this model.

What the Findings Mean

H2HUBB reviewed how molecular hydrogen was evaluated in this publication and summarizes the source-grounded findings below. The mechanism by which hydrogen gas alleviates TBI may be related to inhibiting NLRP3 inflammasomes in the cerebral cortex of rats.

What the Researchers Studied

The study used a preclinical animal experiment.

What Effects Did Molecular Hydrogen Have?

2% inhaled H₂ concentration; reported treatment duration: 1 hour. The mechanism by which hydrogen gas alleviates TBI may be related to inhibiting NLRP3 inflammasomes in the cerebral cortex of rats.

Why These Findings Matter

This publication adds useful evidence about where molecular hydrogen did and did not change the measured outcomes, helping define the larger therapeutic evidence base.

How Strong Is This Evidence?

This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.

Technical Study Details

H2HUBB classifies this publication as animal study with preclinical animal evidence. The reported sample size was 120. The study used a preclinical animal experiment. The reported hydrogen concentration was 2% inhaled H₂ concentration. The reported treatment duration was 1 hour.

Limitations and Safety

No separate limitations or safety findings were identified in the source text available to H2HUBB.

Original Study and H2HUBB Research Context

H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.